• Episode 6: FDA Approves First Drug Treatment for Obstructive Sleep Apnea in Adults with Obesity

  • Dec 23 2024
  • Duración: 3 m
  • Podcast

Episode 6: FDA Approves First Drug Treatment for Obstructive Sleep Apnea in Adults with Obesity

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • In this episode of the Medical News Update, we discuss the FDA's approval of Zepbound (tirzepatide), a groundbreaking drug for treating moderate to severe obstructive sleep apnea in adults with obesity. Learn about the condition, how the medication works, clinical trial results, and potential risks and limitations. Stay informed about the latest medical advancements with our updates.

    00:00 Introduction to Medical News Update

    00:03 FDA Approves Zepbound for Obstructive Sleep Apnea

    00:27 Understanding Obstructive Sleep Apnea

    00:43 How Zepbound Works

    00:58 Clinical Trials and Results

    01:35 Considerations and Risks

    02:06 Conclusion and Final Thoughts

    02:22 Subscribe for More Medical Insights
    Más Menos
Más Menos
adbl_web_global_use_to_activate_webcro768_stickypopup

Lo que los oyentes dicen sobre Episode 6: FDA Approves First Drug Treatment for Obstructive Sleep Apnea in Adults with Obesity

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles